The development of oxidant stress in renal interstitial fibrosis: Role of angiotensin II

被引:0
|
作者
Ricardo, S [1 ]
Cochrane, A [1 ]
机构
[1] Monash Univ, Dept Anat & Cell Biol, Clayton, Vic, Australia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of interstitial fibrosis is an important determinant of renal impairment. The present study evaluates the importance of angiotensin 11 (All) in mediation of reactive oxygen/nitrogen species-induced cell injury and antioxidant enzyme dysfunction leading to the development of interstitial fibrosis. Male Sprague-Dawley rats underwent unilateral ureteral obstruction (UUO) with/without administration of candesartan, an All receptor (AT(1)) inhibitor. Northern blot analysis and antioxidant protein activity demonstrated a restored pattern of Cu-Zn superoxide dismutase (Cu-ZnSOD) and catalase mRNA expression, when UUO rats were administered candesartan. Western blot analysis revealed that candesartan pretreatment of UUO rats significantly decreased nitrotyrosine protein levels, a marker of peroxynitrite production and inducible nitric oxide synthase (iNOS) protein expression, compared to the obstructed kidneys. These studies demonstrate a protective effect of AT, receptor inhibition in UUO rats following a restoration of renal cortical antioxidant status, decreased iNOS and peroxynitrite protein expression, important mediators of extracellular matrix (ECM) accumulation leading to the development of interstitial fibrosis.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 50 条
  • [1] Oxidant stress and regulation of chemokines in the development of renal interstitial fibrosis
    Cochrane, AL
    Ricardo, SD
    RENAL FIBROSIS, 2003, 139 : 102 - 119
  • [2] Prevention of interstitial fibrosis of renal allograft by angiotensin II blockade
    Ishikawa, A.
    Tanaka, M.
    Ohta, N.
    Ozono, S.
    Kitamura, T.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) : 3498 - 3501
  • [3] Angiotensin II and renal fibrosis
    Mezzano, SA
    Ruiz-Ortega, M
    Egido, J
    HYPERTENSION, 2001, 38 (03) : 635 - 638
  • [4] Origin of interstitial fibroblasts in a model of angiotensin II-induced renal fibrosis
    Schlondorff, D
    KIDNEY INTERNATIONAL, 2006, 69 (04) : 647 - 648
  • [5] The role of a2AP in the development of renal interstitial fibrosis
    Kanno, Y.
    Kokado, A.
    Kawashita, E.
    Tani, M.
    Okada, K.
    Ueshima, S.
    Matsuo, O.
    Matsuno, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 438 - 438
  • [6] Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis
    Faulkner, JL
    Szcykalski, LM
    Springer, F
    Barnes, JL
    AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (05): : 1193 - 1205
  • [7] Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
    Chow, Bryna S. Man
    Kocan, Martina
    Bosnyak, Sanja
    Sarwar, Mohsin
    Wigg, Belinda
    Jones, Emma S.
    Widdop, Robert E.
    Summers, Roger J.
    Bathgate, Ross A. D.
    Hewitson, Tim D.
    Samuel, Chrishan S.
    KIDNEY INTERNATIONAL, 2014, 86 (01) : 75 - 85
  • [8] THE ROLE OF MICRORNA-29B IN RENAL FIBROSIS INDUCED BY ANGIOTENSIN II
    Song Lijuan
    Pan, Jialin
    Zhang, Xinwei
    Zhou, Xi
    Huang, Xiaoyan
    Lou, Guoqiang
    Yang, Deye
    Yang Deye
    HEART, 2013, 99 : E49 - E49
  • [9] Angiotensin II, TGF-β and renal fibrosis
    Gaedeke, J
    Peters, H
    Noble, NA
    Border, WA
    RENIN-ANGIOTENSIN SYSTEM AND PROGRESSION OF RENAL DISEASES, 2001, 135 : 153 - 160
  • [10] Local angiotensin II and renal fibrosis in rats
    Sun, Y
    Zhang, JQ
    Zhang, JK
    Ramires, F
    FASEB JOURNAL, 1999, 13 (04): : A483 - A483